We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

Back to rankings

77 hedge funds and large institutions have $497M invested in DIPLOMAT PHARMACY, INC. in 2014 Q4 according to their latest regulatory filings, with 77 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+77
Holders Change %
–
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
77
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$120M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$46.1M
3
NCGI
Next Century Growth Investors
Minnesota
+$29.3M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$24.9M
5
Capital World Investors
Capital World Investors
California
+$22.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$439K +$389K +16,049 New
Deutsche Bank
52
Deutsche Bank
Germany
$390K +$347K +14,307 New
MLICM
53
Metropolitan Life Insurance Company (MetLife)
New York
$387K +$343K +14,146 New
Two Sigma Investments
54
Two Sigma Investments
New York
$385K +$341K +14,060 New
TRSOTSOK
55
Teachers Retirement System of the State of Kentucky
Kentucky
$380K +$337K +13,890 New
CS
56
Credit Suisse
Switzerland
$352K +$312K +12,849 New
BCM
57
Bienville Capital Management
New York
$274K +$243K +10,000 New
GPCM
58
Granite Point Capital Management
Massachusetts
$274K +$243K +10,000 New
AIG
59
American International Group
New York
$269K +$239K +9,841 New
VOYA Investment Management
60
VOYA Investment Management
Georgia
$231K +$205K +8,443 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$220K +$195K +8,050 New
BA
62
BlackRock Advisors
Delaware
$214K +$190K +7,812 New
BIM
63
Bogle Investment Management
Massachusetts
$212K +$188K +7,769 New
SO
64
STRS Ohio
Ohio
$145K +$129K +5,300 New
BJ
65
BlackRock Japan
Japan
$96K +$85.4K +3,520 New
UBS Group
66
UBS Group
Switzerland
$88K +$78.6K +3,240 New
Bank of America
67
Bank of America
North Carolina
$83K +$73.4K +3,024 New
Citigroup
68
Citigroup
New York
$82K +$72.4K +2,985 New
MCM
69
Mazama Capital Management
Oregon
$54K +$47.6K +1,963 New
BlackRock
70
BlackRock
New York
$39K +$34.8K +1,434 New
BBHC
71
Brown Brothers Harriman & Co
New York
$27K +$24.3K +1,000 New
Barclays
72
Barclays
United Kingdom
$26K +$22.8K +940 New
MAA
73
Managed Account Advisors
New Jersey
$16K +$14.3K +588 New
Legal & General Group
74
Legal & General Group
United Kingdom
$14K +$12.5K +517 New
LTFS
75
Ladenburg Thalmann Financial Services
Florida
$8K +$7.28K +300 New
1 2
3
4

DPLO Hedge Fund Activity: Q4 2014 in Review

77 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2014, worth a combined $497M.

Buyers outnumbered sellers: 77 funds opened new DPLO positions and 0 closed out — a net gain of 77 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $120M.

  • 77 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $497M of DIPLOMAT PHARMACY, INC. stock for Q4 2014.
  • 77 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2014 and 0 closed out, a net change of +77 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2014 was T. Rowe Price Associates, an estimated $120M added.

Based on aggregated 13F filings for Q4 2014.